Our proposed mechanism by which IGFBP2 exerts preventive properties in obesity, begins with the ability that IGFBP2 has to prevent and inhibit adipogenesis at local visceral adipose tissue. Here, IGFBP2 is linked to obesity due to melanocortin 4 receptor deficiency.